Advertisement

Topics

Bacterin International Holdings, Inc. Company Profile

12:41 EDT 20th September 2017 | BioPortfolio

Bacterin International Holdings, Inc. (NYSE Amex: BONE) develops, manufactures and markets biologics products to domestic and international markets. Bacterin's proprietary methods optimize the growth factors in human allografts to create the ideal stem cell scaffold to promote bone, subchondral repair and dermal growth. These products are used in a variety of applications including enhancing fusion in spine surgery, relief of back pain, promotion of bone growth in foot and ankle surgery, promotion of cranial healing following neurosurgery and subchondral repair in knee and other joint surgeries.


News Articles [802 Associated News Articles listed on BioPortfolio]

Bacterin Promotes Seasoned Healthcare Sales Professional to National Sales Manager

BELGRADE, Mont., Feb. 7, 2012 /PRNewswire/ -- Bacterin International Holdings, Inc. (NYSE Amex: BONE), a leader in the development of revolutionary bone graft material and antimicrobial coatings ...

Sareum Holdings represents UK at cancer cluster conference

Sareum Holdings Plc (LON:SAR) is to highlight its research pipeline at the 6th annual International Cancer Cluster Showcase at the San Diego Convention Center. Tim Mitchell, chief executive, will be...

Bacterin Study at AAOS 2012 Annual Meeting Shows OsteoSponge® Equivalence to rhBMP-2 in Spinal Fusion; Presented Specifically to Orthopaedic Surgeons

BELGRADE, Mont., Feb. 10, 2012 /PRNewswire/ -- Bacterin International Holdings, Inc. (NYSE Amex: BONE), a leader in the development of revolutionary bone graft material and antimicrobial coa...

Integra LifeSciences Holdings Corp.: Integra LifeSciences to Hold Second International Tissue Technologies Symposium on June 15 - 16, 2017 in Berlin, Germany

PLAINSBORO, N.J., 2017-06-15 09:00 CEST (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART) today announced that it is holding its second International Symposium on Tissue T...

Cosmos Holdings Signs Letter of Intent To Acquire CC Pharma GmbH A Leading Re-importer of EU ...

CHICAGO, IL--(Marketwired - Jun 23, 2017) - Cosmos Holdings, Inc. (the Company) ( OTCQB : COSM), an international pharmaceutical company, announced today that Read more...

Bacterin Retains Hayden IR to Develop Strategic Investor Relations Program

BELGRADE, Mont., Feb. 1, 2012 /PRNewswire/ -- Bacterin International Holdings, Inc. (NYSE Amex: BONE), a leader in the development of revolutionary bone graft material and antimicrobial coati...

Xtant Medical Holdings Inc XTNT Product Pipeline Analysis, 2017 Update [Updated: 18052017] Prices from USD $750

SummaryXtant Medical Holdings Inc Xtant Medical, formerly Bacterin International Holdings, Inc. is a medical device company that develops regenerative medicine products and medical devices. The compan...

GNC Holdings (GNC) & PharMerica (PMC) Critical Analysis

GNC Holdings and PharMerica are both small-cap retail/wholesale companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, in...

PubMed Articles [1625 Associated PubMed Articles listed on BioPortfolio]

Case-control study on the use of pituitary-derived hormones from sheep as a potential risk factor for the occurrence of atypical scrapie in Great Britain.

A case-control study was conducted in 2013 to investigate the use of pituitary-derived hormones from sheep as a potential risk factor for the presence of atypical scrapie in Great Britain sheep holdin...

Efficacy testing of 35-year-old commercially produced ERM bacterin reveals the remarkable stability of this product.

The Sharing Experimental Animal Resources, Coordinating Holdings (SEARCH) Framework: Encouraging Reduction, Replacement, and Refinement in Animal Research.

While significant medical breakthroughs have been achieved through using animal models, our experience shows that often there is surplus material remaining that is frequently never revisited but could...

Modelling virus coinfection to inform management of maize lethal necrosis in Kenya.

Maize lethal necrosis (MLN) has emerged as a serious threat to food security in sub-Saharan Africa. MLN is caused by coinfection with two viruses, maize chlorotic mottle virus (MCMV) and a potyvirus, ...

Organizing an international-standard obstetric ultrasonography training program in a low-resource setting.

Clinical Trials [785 Associated Clinical Trials listed on BioPortfolio]

International AGD Database; Determinants of AGD and Establishment of Normative Data

Aim: To collate data on Anogenital Distance (AGD) from several population studies to build an international database for Anogenital Distance (AGD) Primary objective: To build a database p...

International Study on NoSocomial Pneumonia in Intensive CaRE

The International study on NoSocomial Pneumonia in Intensive CaRE (PneumoINSPIRE) is a prospective, international, multicentre, observational, cohort study. The study aims to provide up-to...

Effectiveness Study of the International Child Development Program

The objective of this study is to evaluate the effect of the International Child Development Program (ICDP). Research questions to be answered: 1. Does the ICDP affect children's psycho...

H-9926-LCH III: Treatment Protocol of the Third International Study for Langerhans Cell Histiocytosis

LCH III is an international, multicentric, prospective clinical study comprised of: - a randomized clinical trial for multisystem "RISK" patients and - a randomized clinical trial ...

Valiant Evo International Clinical Trial

The purpose of the Valiant Evo International Clinical Trial is to demonstrate the safety and effectiveness of the Valiant Evo Thoracic Stent Graft System in subjects with a descending thor...

Companies [1633 Associated Companies listed on BioPortfolio]

Bacterin International Holdings, Inc.

Bacterin International Holdings, Inc. (NYSE Amex: BONE) develops, manufactures and markets biologics products to domestic and international markets. Bacterin's proprietary meth...

Bacterin International, Inc

Bacterin International develops novel anti-infective coatings based on proprietary knowledge of the physiological changes made by microbes as they sense and adapt to changes in their environment. We m...

Bacterin International, Inc.

AFT Holdings, Inc.

AFT Holdings, Inc. is an international investment and management group with a diverse portfolio including commercial and residential real estate, sustainable foods development, gl...

Changda International Holdings, Inc.

Changda International Holdings, Inc., through its wholly owned subsidiaries, Weifang Changda Chemical Industry Co., Ltd. and Weifang Changda Fertilizer Co., Ltd., produces compoun...

More Information about "Bacterin International Holdings, Inc." on BioPortfolio

We have published hundreds of Bacterin International Holdings, Inc. news stories on BioPortfolio along with dozens of Bacterin International Holdings, Inc. Clinical Trials and PubMed Articles about Bacterin International Holdings, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Bacterin International Holdings, Inc. Companies in our database. You can also find out about relevant Bacterin International Holdings, Inc. Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topic

Osteoporosis
Osteoporosis is a disease in which the bones become extremely porous, are subject to fracture, and heal slowly, occurring especially in women following menopause and often leading to curvature of the spine from vertebral collapse. Follow and track&n...


Corporate Database Quicklinks



Searches Linking to this Company Record